Simpirica Spine, Inc., based in San Carlos, California, was established in 2006 based on research performed as part of Stanford University’s Biodesign Innovation program with the goal to develop and market Simple, Empirical Spinal Solutions™.
The company’s lead product, the LimiFlex™ Paraspinous Tension Band, received the CE-mark in 2009. It is a novel implant that provides segmental stability to the lumbar spine while still allowing motion. The LimiFlex™ Paraspinous Tension Band has been designed for patients with degenerative lumbar spinal disorders requiring segmental stabilization for which the current standard surgical option is invasive and costly spinal fusion.
After several clinical studies outside the United States, the LimiFlex™ Paraspinous Tension Band was commercially launched in Europe. An experienced team at Simpirica Spine GmbH directly supports sales in Germany, and the United Kingdom, Austria and further European markets are managed by select distributors. A randomized clinical trial has been approved by the United States FDA under an Investigational Device Exemption (IDE) to study use of LimiFlex™ in patients with Grade I degenerative spondylolisthesis.
Dedicated employees and a strong management team on both sides of the Atlantic bring profound, global experience in orthopedic and spinal surgery to Simpirica Spine.
Introduction to LimiFlex™: Video by Todd F. Alamin, MD.1
1. Todd F. Alamin, MD, orthopedic spine surgeon at Stanford University School of Medicine and co-founder of Simpirica Spine